Aesocytidine in MDS and CMML - A Review

This work has important implications beyond the use of aesocytidine in MDS and CMML. It highlights that not all findings from one myeloid malignancy can be applied to other malignancies. The majority of VTE events in glioma are associated with surgical resection or adjuvant therapy. Other factors that may increase the risk of VTE include older age, large tumor size,. higher VTE, leg perisis, and A or AB blood type.